Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02457663 · ClinicalTrials.gov registry record

Identification and Validation of Biomarkers for Infections in Burns

A clinical trial, sponsored by The University of Texas Medical Branch, Galveston.

Terminated
Registry status
19
Enrollment target

NCT02457663 is a clinical trial that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 19 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02457663 was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.

TERMINATED
Registry status
19 participants
Enrollment target

Study Summary

In this prospective, multi-center study, 200 patients from four participating Texas burn hospitals will be enrolled from admission to discharge. The clinical research study team will collect approximately 11 serum samples and clinical data related to sepsis and infection predictors from severely burned adult patients, ages 18-80 years old. All serum samples from participating sites will be shipped to the lead site, University of Texas Medical Branch. The University of Texas Medical Branch will then validate previously identified biomarkers while simultaneously identifying novel biomarkers through discovery proteomics.

Interventions

  • PROCEDURE Blood Draw

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2015-04
Est. Completion 2019-07-11

What the Registry Record Tells You About NCT02457663

The ClinicalTrials.gov registry entry for NCT02457663 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Blood Draw is the first listed.

NCT02457663 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02457663 about?

NCT02457663 is a clinical study titled "Identification and Validation of Biomarkers for Infections in Burns". In this prospective, multi-center study, 200 patients from four participating Texas burn hospitals will be enrolled from admission to discharge. The clinical research study team will collect approximately 11 serum samples and clinical data related to sepsis and infection predictors from severely bur...

What is the current status of trial NCT02457663?

This trial is currently terminated. The enrollment target is 19 participants. The study started on 2015-04. Estimated completion is 2019-07-11.

What interventions are being tested in trial NCT02457663?

The interventions under investigation include: Blood Draw (PROCEDURE).

Who is sponsoring clinical trial NCT02457663?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.